WA

Washington Pharmaceutical Services, LLC

  • CIK: 0001311341
  • EIN: 27-0026536
  • Business address: C/O US ONCOLOGY, INC., 16825 NORTHCHASE DRIVE, SUITE 1300, HOUSTON, Texas, 77060

Information

  • Mailing address
    C/O US ONCOLOGY, INC., 16825 NORTHCHASE DRIVE, SUITE 1300, HOUSTON, Delaware, 77060
  • Phone
    832-601-8766
  • State location
    Texas
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    8093 - (CF Office: Office of Life Sciences) SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC
  • Filings
    N/A

About Washington Pharmaceutical Services, LLC

Washington Pharmaceutical Services, LLC (CIK: 0001311341) is an American company incorporated in the state of Texas. Head office is located at C/O US ONCOLOGY, INC., 16825 NORTHCHASE DRIVE, SUITE 1300, HOUSTON, Texas, 77060. Work in the industry 8093 - (CF Office: Office of Life Sciences) SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC. Washington Pharmaceutical Services, LLC is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Washington Pharmaceutical Services, LLC

Filings Format Description Filed/Effective File/Film Number
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0001047469-05-006794 (33 Act) Size: 1771 KB		 Mar-16-2005

333-121410-15

05686183
S-4/A Document

Amendment to Registration of securities issued in business combination transactions

Acc-no: 0001047469-05-006677 (33 Act) Size: 2009 KB		 Mar-16-2005

333-121410-15

05684172
S-4/A Document

Amendment to Registration of securities issued in business combination transactions

Acc-no: 0001047469-05-006294 (33 Act) Size: 2025 KB		 Mar-14-2005

333-121410-15

05677107
S-4 Document

Registration of securities issued in business combination transactions

Acc-no: 0001047469-04-037612 (33 Act) Size: 11648 KB		 Dec-17-2004

333-121410-15

041211857

Recent 20 filings. View all Washington Pharmaceutical Services, LLC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • Washington Pharmaceutical Services, LLC overview
  • Washington Pharmaceutical Services, LLC job
  • Washington Pharmaceutical Services, LLC stock
  • Washington Pharmaceutical Services, LLC ownership
  • Washington Pharmaceutical Services, LLC CEO
  • Washington Pharmaceutical Services, LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Concentra Group Holdings Parent, Inc.
Update: Jun 15, 2024
VISTA LASER CENTERS OF MICHIGAN INC
Update: Aug 24, 2022
VAKOUTIS JOHN
Update: Aug 24, 2022
US Oncology Pharmaceutical Services, LLC
Update: Aug 24, 2022
UCI MEDICAL AFFILIATES INC
Update: Aug 24, 2022
U.S. NeuroSurgical Holdings, Inc.
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 3412 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3438 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1292 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2019 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4163 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2914 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4571 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 4144 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2353 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by